Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis obliterans in children.

Geoffrey Kurland1, Peter Michelson

  • 1Division of Pediatric Pulmonology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. geoffrey.kurland@chp.edu

Pediatric Pulmonology
|January 7, 2005
PubMed
Summary

Bronchiolitis obliterans (BO) is a rare pediatric complication following transplantation or other exposures. Early recognition and improved therapies are crucial due to uncertain prognosis and limited treatment success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Sustained immune and pulmonary recovery three years after hematopoietic stem cell transplantation for ITCH E3 ubiquitin ligase deficiency.

Frontiers in immunology·2026
Same author

Durable hematopoiesis and tolerance after vertebral bone marrow transplant from a deceased lung transplant donor.

JCI insight·2026
Same author

A Hypomorphic Variant in Surfactant Protein B Deficiency: Survival of Two Patients.

Pediatric pulmonology·2025
Same author

Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.

The Lancet. Respiratory medicine·2025
Same author

Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease.

Thorax·2024
Same author

The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort.

Pediatric pulmonology·2023

Area of Science:

  • Pediatric Pulmonology
  • Transplantation Medicine
  • Toxicology

Background:

  • Bronchiolitis obliterans (BO) is a rare but serious condition in children.
  • It is increasingly recognized as a complication of pediatric lung and bone marrow transplantation.
  • BO can also result from various illnesses and toxic exposures.

Purpose of the Study:

  • To review the current understanding of Bronchiolitis obliterans in children.
  • To highlight the challenges in diagnosis, pathogenesis, and treatment.
  • To identify critical areas for future research and therapeutic development.

Main Methods:

  • This review synthesizes existing literature on Bronchiolitis obliterans.
  • It discusses the pathology, pathogenesis, and molecular aspects of BO.

Related Experiment Videos

  • The article examines BO in the context of transplantation and other etiologies.

    • Main Results:

    • Bronchiolitis obliterans has a complex and not fully understood pathology and pathogenesis.
    • Prognosis for BO is uncertain, and current treatments are often unsuccessful.
    • There is a critical need for identifying surrogate markers and developing novel therapies.

    Conclusions:

    • Further research into the molecular pathology of BO is essential.
    • Developing effective preventative strategies and treatments for pediatric BO is paramount.
    • Continued investigation is required to improve outcomes for affected children.